Acquired purpura fulminans

It is the purpose of this review to discuss the pathogenesis, clinical features, and treatment of acquired purpura fulminans, within the context of recent advances in our understanding of the regulation of coagulation, the physiology of vascular endothelial cells, and the host response to immunologic challenge